Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,441.10
-0.20 (-0.01%)
Jul 10, 2026, 1:40 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.16 trillion as of July 9, 2026. Its market cap has decreased by -2.87% in one year.
Market Cap
1.16T
Enterprise Value
1.07T
Revenue
278.28B
Ranking
n/a
PE Ratio
30.03
Stock Price
1,441.10
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.16T, an increase of 76,816.25%. That is a compound annual growth rate of 24.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.16T | -4.63% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.80T |
| Zydus Lifesciences | 1.15T |
| Mankind Pharma | 1.04T |
| Aurobindo Pharma | 896.09B |
| Laurus Labs | 797.58B |
| Alkem Laboratories | 670.28B |
| Glenmark Pharmaceuticals | 639.16B |
| Ipca Laboratories | 454.92B |